Evidence map›Paper›PMID 33320935›Full record

ArticleTransactions of the Royal Society of Tropical Medicine and Hygiene2021

Development of the Global Mycetoma Working Group.

Rita M Traxler, Karlyn D Beer, David D Blaney, Wendy W J van de Sande, Ahmed H Fahal, Kingsley B Asiedu, William A Bower, Tom Chiller

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Transactions of the Royal Society of Tropical Medicine and Hygiene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Deep and disseminated dermatophytosis in immunocompromised populations-A systematic review.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Pooled it
  2. Article
  3. Towards enhanced control of mycetoma: a roadmap to achieve the UN's sustainable development goals by 2030.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2024
    Article
  4. Review
  5. A scoping review of mycetoma profile in Egypt: revisiting the global endemicity map.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2023
    Article
  6. Updated Review onClinical microbiology reviews · 2022
    Review
  7. Why the mycetoma patients are still neglected.PLoS neglected tropical diseases · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Rita M TraxlerNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS 24-12, Atlanta GA 30329, USA.
Karlyn D BeerNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS 24-12, Atlanta GA 30329, USA.
David D BlaneyNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS 24-12, Atlanta GA 30329, USA.
Wendy W J van de SandeDepartment of Medical Microbiology & Infectious Diseases, Erasmus Medical Center, Na-903, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
Ahmed H FahalMycetoma Research Center, Soba University Hospital, PO Box 102, Khartoum, Sudan.
Kingsley B AsieduDepartment of Control of Neglected Tropical Diseases, World Health Organization, WHO Headquarters, Avenue Appia 20, 1211, Geneva 27, Switzerland.
William A BowerNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS 24-12, Atlanta GA 30329, USA.
Tom ChillerNational Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE MS 24-12, Atlanta GA 30329, USA.
Centers for Disease Control and Prevention · USWorld Health Organization · CH

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

The Global Mycetoma Working Group (GMWG) was formed in January 2018 in response to the declaration of mycetoma as a neglected tropical disease (NTD) by the World Health Assembly. The aim of the working group is to connect experts and public health practitioners around the world to accelerate mycetoma prevention activities and reduce the impact of mycetoma on patients, healthcare providers and society in the endemic regions. The working group has made tangible contributions to mycetoma programming, awareness and coordination among scientists, clinicians and public health professionals. The group's connectivity has enabled rapid response and review of NTD documents in development, has created a network of public health professionals to provide regional mycetoma expertise and has enabled mycetoma to be represented within broader NTD organizations. The GMWG will continue to serve as a hub for networking and building collaborations for the advancement of mycetoma clinical management and treatment, research and public health programming.

Indexed as

MycetomaGlobal HealthHumansNeglected DiseasesPublic Healthcoalitionglobal healthmycetomaneglected tropical disease

Identifiers

PMID33320935
PMCPMC9423010
OpenAlexW3111466233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.